Deal of the Day — limited-time pharmacy picks!
Nexipox Vaccine 0.5ml Vaccine

Nexipox Vaccine 0.5ml Vaccine

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Varicella Vaccine , Live IP Freeze Dried

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Vial in a Pack

About The Product

Chikenpox

Nexipox Vaccine 0.5ml Vaccine contains Varicella Vaccine (live) attenuated (2000PFU) as an active ingredient. It is indicated for active immunization for prevention of chickenpox in individuals 12 months of age & older. This injection should be given under the skin or into the muscle of the upper arm in two doses.

Uses

Prevention of Chickenpox


Side Effects

Side effects are unwanted symptoms that can occur from any medical treatment. Like other medications, the Nexipox Vaccine 0.5ml Vaccine can also have adverse effects on the body, most of which resolve without the need for medical attention.

Some common side effects include:

  • Injection site reactions (pain, swelling, redness)
  • Headache
  • Irritation
  • Drowsiness
  • Loss of appetite

Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • Nexipox Vaccine 0.5ml Vaccine should be given by an experienced nurse or doctor.
  • Please do not self-administer.It is given to children between 12 months to 12 years of age.
  • Also the second dose should be given after a minimum gap of 3 months.
  • For adolescents & adults as well, it is given in two doses a minimum of 4 weeks apart.

How It Works

  • Nexipox Vaccine 0.5ml Vaccine contains Varicella Vaccine (live) attenuated (2000PFU) as an active ingredient.
  • This vaccine helps to develop immunity by initiating a mild infection also this type of infection does not cause illness.
  • Mild infection caused by vaccine stimulate the body's immune system to produce antibodies to protect against any future infections.
  • It can be given from children between 12 months to 12 years of age and to adolescents and adults as well. Vaccination is the best way to prevent chickenpox.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Nexipox Vaccine 0.5ml Vaccine, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Do not take Nexipox Vaccine 0.5ml Vaccine without consulting the doctor in case of pregnancy, as it is an unsafe to take it during this period.
Breast Feeding
Nexipox Vaccine 0.5ml Vaccine is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
Driving
Nexipox Vaccine 0.5ml Vaccine may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Nexipox Vaccine 0.5ml Vaccine is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Liver
Nexipox Vaccine 0.5ml Vaccine is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

FAQs

Nexipox Vaccine 0.5ml Vaccine is indicated for active immunization for prevention of chickenpox in individuals 12 months of age & older.

References

  • Liu, H., Cui, L., Zhang, S., Wang, H., Xue, W., Li, H., ... & Li, S. (2025). Research Progress on Varicella-Zoster Virus Vaccines. Vaccines, 13(7), 730.
  • Grose, C., Friedrichs, W. E., & Smith, K. O. (1981). Cryopreservation of varicella-zoster virions without loss of structural integrity or infectivity. Intervirology, 15(3), 154-160.
  • AboulFotouh, K., Xu, H., Moon, C., Williams III, R. O., & Cui, Z. (2022). Development of (inhalable) dry powder formulations of AS01B-containing vaccines using thin-film freeze-drying. International Journal of Pharmaceutics, 622, 121825.
  • Hansen, L. J. J., Daoussi, R., Vervaet, C., Remon, J. P., & De Beer, T. R. M. (2015). Freeze-drying of live virus vaccines: A review. Vaccine, 33(42), 5507-5519.
  • Wui, S. R., Kim, K. S., Ryu, J. I., Ko, A., Do, H. T. T., Lee, Y. J., ... & Lee, N. G. (2019). Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice. Vaccine, 37(15), 2131-2141.
  • Garg, P., Garg, S. P., Sharma, M. K., & Sahani, S. (2014). Phase-I, open, unicentric clinical trial for evaluation of safety of varicella vaccine, live (IP)(Oka strain) in adults. Biotechnology International, 7, 26-34.​

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026